Valuation Valerio Therapeutics Deutsche Boerse AG

Stocks

Market Closed - Deutsche Boerse AG Other stock markets 02:01:01 2026-06-16 EDT			5-day change	1st Jan Change
0.1760 ^EUR	-2.76%		-9.09%	+23.94%

05-19	Valerio Therapeutics Signs Binding Term-sheet for V-Body Platform Collaboration	MT
05-18	Valerio Therapeutics enters into collaboration & exclusive license with seed-stage biotech co	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	52.01	38.52	15.64	25.42	11.55	67.46
Change	-	-25.93%	-59.41%	62.58%	-54.58%	484.18%
Enterprise Value (EV) ¹	43.74	30.57	11.19	29.61	26.93	74.72
Change	-	-30.12%	-63.41%	164.7%	-9.03%	177.44%
P/E Ratio	66.7x	-6x	-0.76x	-1.1x	-0.47x	-6.9x
PBR	1.79x	1.17x	0.7x	1.72x	-1.29x	33.2x
PEG	-	0x	-0x	0.1x	-0.07x	0.1x
Capitalization / Revenue	29.3x	9.48x	10.8x	14.1x	6.44x	26.2x
EV / Revenue	24.6x	7.53x	7.75x	16.4x	15x	29x
EV / EBITDA	-5.69x	-5.52x	-0.66x	-1.57x	-6.91x	21.7x
EV / EBIT	-5.6x	-5.48x	-0.65x	-1.55x	-1.63x	-136x
EV / FCF	-4.87x	-4.16x	-3.83x	-3.02x	4.67x	-101x
FCF Yield	-20.5%	-24.1%	-26.1%	-33.1%	21.4%	-0.99%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	0.01	-0.07	-0.185	-0.1505	-0.16	-0.02
Distribution rate	-	-	-	-	-	-
Net sales ¹	1.776	4.062	1.443	1.8	1.793	2.573
EBITDA ¹	-7.69	-5.535	-17.04	-18.92	-3.896	3.45
EBIT ¹	-7.814	-5.582	-17.11	-19.05	-16.49	-0.55
Net income ¹	1.089	-5.937	-19.56	-20.34	-23.93	-4.898
Net Debt ¹	-8.266	-7.953	-4.452	4.184	15.38	7.26
Reference price ²	0.6670	0.4200	0.1408	0.1650	0.0750	0.1380
Nbr of stocks (in thousands)	77,977	91,722	111,059	154,077	153,972	488,848
Announcement Date	4/23/21	4/28/22	4/29/23	5/2/24	7/9/25	4/28/26

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	33.05x	12.01x	24.74x	0.6%	1,007B
JOHNSON & JOHNSON	25.19x	5.81x	15.79x	2.26%	567B
ABBVIE INC.	27.13x	6.62x	13.53x	3.1%	392B
ROCHE HOLDING AG	17.5x	4.32x	10.61x	3.07%	328B
NOVARTIS AG	20.98x	5.43x	13.17x	2.95%	277B
ASTRAZENECA PLC	22.23x	4.65x	13.18x	1.88%	275B
NOVO NORDISK A/S	12.63x	4.73x	9.67x	3.97%	196B
AMGEN INC.	22.79x	6.1x	10.65x	2.88%	189B
GILEAD SCIENCES, INC.	-44.54x	5.38x	29.66x	2.61%	154B
Average	15.22x	6.12x	15.67x	2.59%	376.23B
Weighted average by Cap.	22.38x	7.41x	17.25x	2.12%